Neogen | NEOG - Operating Expenses


Neogen reported $214.5M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Agilent USD 1.44B 9M Mar/2026
Avanos Medical USD 782.1M 625.97M Mar/2026
Bio-Rad Laboratories USD 6.85B 6.21B Mar/2026
Cerus USD 34.78M 2.98M Dec/2024
Danaher USD 52.95B 47.61B Mar/2026
Idexx Laboratories USD 778.23M 3.26M Mar/2026
Illumina USD 852M 51M Mar/2026
Integra LifeSciences USD 1.04B 673.49M Mar/2026
Neogen USD 214.5M 15.57M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Quidel USD 1.85B 1.09B Mar/2026
Rockwell Medical USD 30.41M 1.11M Jun/2025
STAAR Surgical USD 76.12M 7.38M Mar/2026
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Utah Medical Products USD 6.6M 354K Dec/2025
Zoetis USD 3.23B 1.68B Mar/2026